Search Results | Scholarly Articles, Journals, and E-Books

Results: 11

Editorial.
Published in:
2016
By:
- Mikolajczak, Renata;
- Kamiński, Grzegorz
Publication type:
Editorial
Radiopharmaceuticals for somatostatin receptor imaging.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 126, doi. 10.5603/NMR.2016.0024
By:
- Mikotajczak, Renata;
- Maecke, Helmut R.
Publication type:
Article
Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 99, doi. 10.5603/NMR.2016.0020
By:
- Artiko, Vera;
- Afgan, Aida;
- Petrović, Jelena;
- Radović, Branislava;
- Petrović, Nebojša;
- Vlajković, Marina;
- Šobić-Šaranović, Dragana;
- Obradović, Vladimir
Publication type:
Article
Oxidation of methionine -- is it limiting the diagnostic properties of 99mTc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist?
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 104, doi. 10.5603/NMR.2016.0021
By:
- Janota, Barbara;
- Karczmarczyk, Urszula;
- Laszuk, Ewa;
- Garnuszek, Piotr;
- Mikołajczak, Renata
Publication type:
Article
NEN -- the role of somatostatin receptor scintigraphy in clinical setting.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 118, doi. 10.5603/NMR.2016.0023
By:
- Opalinska, Marta;
- Hubalewska-Dydejczyk, Alicja;
- Sowa-Staszczak, Anna;
- Stefanska, Agnieszka
Publication type:
Article
Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 81, doi. 10.5603/NMR.2016.0017
By:
- Sergieva, Sonya;
- Robev, Bozhil;
- Dimcheva, Milena;
- Fakirova, Albena;
- Hristoskova, Radka
Publication type:
Article
Limitations and pitfalls of 99mTc-EDDA//HYNIC-TOC (Tektrotyd) scintigraphy.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 93, doi. 10.5603/NMR.2016.0019
By:
- Garai, Ildiko;
- Barna, Sándor;
- Nagy, Gabor;
- Forgács, Attila
Publication type:
Article
Neuroendocrine neoplasms and somatostatin receptor subtypes expression.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 111, doi. 10.5603/NMR.2016.0022
By:
- Hankus, Jerzy;
- Tomaszewska, Romana
Publication type:
Article
99mTc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 67, doi. 10.5603/NMR.2016.0015
By:
- Czepczyński, Rafał;
- Gryczyńska, Maria;
- Ruchała, Marek
Publication type:
Article
99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 74, doi. 10.5603/NMR.2016.0016
By:
- Trogrlic, Mate;
- Tezak, Stanko
Publication type:
Article
Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Published in:
Nuclear Medicine Review, 2016, v. 19, n. 2, p. 88, doi. 10.5603/NMR.2016.0018
By:
- Mądrzak, Dorota;
- Mikotajczak, Renata;
- Kamiński, Grzegorz
Publication type:
Article

Editorial.

Radiopharmaceuticals for somatostatin receptor imaging.

Evaluation of neuroendocrine tumors with <sup>99m</sup>Tc-EDDA/HYNIC TOC.

Oxidation of methionine -- is it limiting the diagnostic properties of <sup>99m</sup>Tc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist?

NEN -- the role of somatostatin receptor scintigraphy in clinical setting.

Clinical application of SPECT-CT with <sup>99m</sup>Tc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).

Limitations and pitfalls of <sup>99m</sup>Tc-EDDA//HYNIC-TOC (Tektrotyd) scintigraphy.

Neuroendocrine neoplasms and somatostatin receptor subtypes expression.

<sup>99m</sup>Tc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment.

<sup>99m</sup>Tc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.

Influence of PET/CT <sup>68</sup>Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with <sup>99m</sup>Tc-EDDA/HYNIC-TOC SPECT.